Sutro Biopharma (STRO) Current Assets (2017 - 2025)

Sutro Biopharma (STRO) has 9 years of Current Assets data on file, last reported at $150.9 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets fell 56.04% year-over-year to $150.9 million; the trailing twelve-month figure through Dec 2025 stood at $150.9 million (down 56.04% YoY), and the FY2025 full-year result was $150.9 million, down 56.04% from the prior year.
• Current Assets retreated to $150.9 million in Q4 2025, from $182.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $443.5 million in Q2 2024 to a low of $150.9 million in Q4 2025.
• A 5-year average of $309.5 million and a median of $317.8 million in 2022 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 108.7% in 2021 and slumped 56.04% in 2025, its largest moves.
• Tracing STRO's Current Assets over 5 years: stood at $218.5 million in 2021, then surged by 61.61% to $353.2 million in 2022, then advanced by 19.37% to $421.5 million in 2023, then fell by 18.56% to $343.3 million in 2024, then sank by 56.04% to $150.9 million in 2025.
• Business Quant data shows STRO's Current Assets at $150.9 million in Q4 2025, $182.1 million in Q3 2025, and $231.6 million in Q2 2025.